Yahoo Finance Global Vitamin D Therapy Market to Reach $4.2 Billion by 2027
Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8. - Influencer Pool: 1249. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.
New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vitamin D Therapy Industry" - https://www.reportlinker.com/p06033260/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.
Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.
Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.
Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.
Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.
Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.
Abstract:
- Global Vitamin D Therapy Market to Reach $4.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Vitamin D Therapy estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$4.2 Billion by 2027, growing at aCAGR of 10.8% over the period 2020-2027. Oral, one of the segments analyzed in the report, is projected to record 11.1% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Parenteral segment is readjusted to a revised 10.1% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $610.2 Million, While China is Forecast to Grow at 10.4% CAGR
- The Vitamin D Therapy market in the U.S. is estimated at US$610.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$743.7 Million by the year 2027 trailing a CAGR of 10.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.5% and 9.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.
Select Competitors (Total 36 Featured) -
Abbott
Alkem Laboratories Ltd.
Cadila Healthcare Ltd.
GlaxoSmithKline PLC
Merck & Co., Inc.
Novartis AG
Pfizer Inc
Sanofi
Sun Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Ltd.
Read the full report: https://www.reportlinker.com/p06033260/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Vitamin D Therapy Competitor Market Share Scenario Worldwide:
(in %): 2020E
Global Competitor Market Shares by Segment
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Vitamin D Therapy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 2: World Historic Review for Vitamin D Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 3: World 15-Year Perspective for Vitamin D Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Oral by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Oral by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Oral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 7: World Current & Future Analysis for Parenteral by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 8: World Historic Review for Parenteral by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Parenteral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 10: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 11: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 12: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Osteoporosis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 14: World Historic Review for Osteoporosis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Osteoporosis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Rickets by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 17: World Historic Review for Rickets by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Rickets by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 19: World Current & Future Analysis for Muscle Weakness
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 20: World Historic Review for Muscle Weakness by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 21: World 15-Year Perspective for Muscle Weakness by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Autoimmune
Disorders by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 23: World Historic Review for Autoimmune Disorders by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 24: World 15-Year Perspective for Autoimmune Disorders by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 25: World Current & Future Analysis for Skin Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 26: World Historic Review for Skin Diseases by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Skin Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for Prescription
Drugs by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 29: World Historic Review for Prescription Drugs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 30: World 15-Year Perspective for Prescription Drugs by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 31: World Current & Future Analysis for OTC Drugs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 32: World Historic Review for OTC Drugs by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 33: World 15-Year Perspective for OTC Drugs by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
Market Analytics
Table 34: USA Current & Future Analysis for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 35: USA Historic Review for Vitamin D Therapy by Route Of
Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 36: USA 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027
Table 37: USA Current & Future Analysis for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 38: USA Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 39: USA 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 40: USA Current & Future Analysis for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 41: USA Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 42: USA 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027
CANADA
Table 43: Canada Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 44: Canada Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 45: Canada 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027
Table 46: Canada Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 47: Canada Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 48: Canada 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 49: Canada Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 50: Canada Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 51: Canada 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027
JAPAN
Table 52: Japan Current & Future Analysis for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 53: Japan Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 54: Japan 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027
Table 55: Japan Current & Future Analysis for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 56: Japan Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 57: Japan 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 58: Japan Current & Future Analysis for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 59: Japan Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 60: Japan 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027
CHINA
Table 61: China Current & Future Analysis for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 62: China Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 63: China 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027
Table 64: China Current & Future Analysis for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 65: China Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 66: China 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 67: China Current & Future Analysis for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 68: China Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 69: China 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027
EUROPE
Market Facts & Figures
Market Analytics
Table 70: Europe Current & Future Analysis for Vitamin D
Therapy by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 71: Europe Historic Review for Vitamin D Therapy by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 72: Europe 15-Year Perspective for Vitamin D Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2020 & 2027
Table 73: Europe Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 74: Europe Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 75: Europe 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027
Table 76: Europe Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 77: Europe Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 78: Europe 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 79: Europe Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 80: Europe Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 81: Europe 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027
FRANCE
Table 82: France Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 83: France Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 84: France 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027
Table 85: France Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 86: France Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 87: France 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 88: France Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 89: France Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 90: France 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027
GERMANY
Table 91: Germany Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 92: Germany Historic Review for Vitamin D Therapy by
Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 93: Germany 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027
Table 94: Germany Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 95: Germany Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 96: Germany 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 97: Germany Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 98: Germany Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 99: Germany 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027
ITALY
Table 100: Italy Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 101: Italy Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 102: Italy 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027
Table 103: Italy Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 104: Italy Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 105: Italy 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 106: Italy Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 107: Italy Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 108: Italy 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 109: UK Current & Future Analysis for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 110: UK Historic Review for Vitamin D Therapy by Route Of
Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 111: UK 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027
Table 112: UK Current & Future Analysis for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 113: UK Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 114: UK 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 115: UK Current & Future Analysis for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 116: UK Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 117: UK 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027
REST OF EUROPE
Table 118: Rest of Europe Current & Future Analysis for Vitamin
D Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 119: Rest of Europe Historic Review for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 120: Rest of Europe 15-Year Perspective for Vitamin D
Therapy by Route Of Administration - Percentage Breakdown of
Value Sales for Oral and Parenteral for the Years 2012, 2020 &
2027
Table 121: Rest of Europe Current & Future Analysis for Vitamin
D Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 122: Rest of Europe Historic Review for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 123: Rest of Europe 15-Year Perspective for Vitamin D
Therapy by Application - Percentage Breakdown of Value Sales
for Other Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 124: Rest of Europe Current & Future Analysis for Vitamin
D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 125: Rest of Europe Historic Review for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 126: Rest of Europe 15-Year Perspective for Vitamin D
Therapy by Method - Percentage Breakdown of Value Sales for
Prescription Drugs and OTC Drugs for the Years 2012, 2020 &
2027
ASIA-PACIFIC
Table 127: Asia-Pacific Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 128: Asia-Pacific Historic Review for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 129: Asia-Pacific 15-Year Perspective for Vitamin D
Therapy by Route Of Administration - Percentage Breakdown of
Value Sales for Oral and Parenteral for the Years 2012, 2020 &
2027
Table 130: Asia-Pacific Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 131: Asia-Pacific Historic Review for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 132: Asia-Pacific 15-Year Perspective for Vitamin D
Therapy by Application - Percentage Breakdown of Value Sales
for Other Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027
Table 133: Asia-Pacific Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 134: Asia-Pacific Historic Review for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 135: Asia-Pacific 15-Year Perspective for Vitamin D
Therapy by Method - Percentage Breakdown of Value Sales for
Prescription Drugs and OTC Drugs for the Years 2012, 2020 &
2027
REST OF WORLD
Table 136: Rest of World Current & Future Analysis for Vitamin
D Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 137: Rest of World Historic Review for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 138: Rest of World 15-Year Perspective for Vitamin D
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033260/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
